PCSK9 and Insulin resistance: The role of SREBP-1c in the regulation of PCSK9 levels has also been observed in humans, where PCSK9 is positively correlated with insulin resistance, liver steatosis, and very low-density lipoprotein-triglyceride (VLDL-TG) levels [17].